Metagenomi Therapeutics MGX
NASDAQ MGX
$0.80 -0.01 (-1.73%)
As of: Oct 23, 2026 · 2:03 PM EDT

Metagenomi Therapeutics (MGX) Net Shares Issued and Repurchased (2023 - 2025)

Updated

Analysis

Metagenomi Therapeutics (MGX) Net Shares Issued and Repurchased (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,126.20 Bn 1,094.78 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 633.36 Bn 553.22 Bn 17.30 Bn -966.00 Mn
3 AbbVie 504.51 Bn 477.62 Bn 12.70 Bn -9.00 Mn
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 289.65 Bn 253.64 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 264.97 Bn 238.66 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.69 Bn 193.09 Bn 7.24 Bn -
8 Gilead Sciences 194.48 Bn 168.68 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Metagenomi Therapeutics 30.21 Mn -575.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 109,000.00
Sep 30, 2024 -492,000.00
Jun 30, 2024 -2.03 Mn
Mar 31, 2024 86.54 Mn
Dec 31, 2023 -1.33 Mn
Sep 30, 2023 -1.91 Mn
API Access

Metagenomi Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=MGX&period=max&api_key=YOUR_API_KEY